Green tea technology comes to market
This article was originally published in The Rose Sheet
Executive SummaryProcter & Gamble names Wuxi Green Power Bio-Products exclusive Chinese licensee for solvent-free green tea processing technology, company announces Jan. 29. Green Power will use technology to manufacture green tea with high concentrations of antioxidant polyphenol for use by P&G and for sale to cosmetic, nutritional and beverage manufacturers, P&G adds. License by Green Power will mark the first time P&G and other firms will be able to use technology in cosmetics and other products. Technology involves "physical separation" rather than by chemicals, resulting in a cleaner product, P&G claims. Green Power has appointed City of Industry, Calif.-based Amax Nutritional as its exclusive North American distributor...
You may also be interested in...
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.
A PFS benefit and favorable tolerability profile associated with AstraZeneca’s BTK inhibitor acalabrutinib used first-line in CLL, when given alone or combined with obinutuzumab, may serve it well against entrenched competitors and BTK inhibitors in clinical development.
Amneal has acquired a majority stake in manufacturer and wholesaler AvKARE, giving the firm access to the “large, complex and growing federal healthcare market.”